Schisandrol B, CAS [[58546-54-6]]

Catalog Number: TGM-T6S1917
Article Name: Schisandrol B, CAS [[58546-54-6]]
Biozol Catalog Number: TGM-T6S1917
Supplier Catalog Number: T6S1917
Alternative Catalog Number: TGM-T6S1917-1MLX10MM(INDMSO),TGM-T6S1917-5MG,TGM-T6S1917-10MG,TGM-T6S1917-25MG,TGM-T6S1917-50MG,TGM-T6S1917-100MG,TGM-T6S1917-500MG
Manufacturer: TargetMol
Category: Biochemikalien
Alternative Names: Gomisin A , TJN-101 , Besigomsin , Gamma-Schisandrin , Schizandrol B , Wuweizi alcohol-B
1. Schisandrol B (Besigomsin) may exert neuroprotective effects by attenuating the microglia-mediated neuroinflammatory response via inhibiting the TLR4-mediated NF-kappaB and MAPKs signaling pathways. 2. Schisandrol B has anti-inflammatory property, potentially result from the inhibition of COX-2, iNOS, IL-6, TNF-alpha and NO through the down-regulation of RIP2 and NF-kappaB activation. 3. Schisandrol B induces marked protective effects against hepatic and renal injury induced by CCl(4) exposure through differential regulation of the MAPK signal transduction pathway. 4. Schisandrol B significantly inhibits cell proliferation in a dose-dependent manner, due to cell cycle arrest in the G1 phase with the downregulation of cyclin D1 expression and Retinoblastoma (RB) phosphorylation.
Molecular Weight: 416.46
Purity: 99.14%
CAS Number: [58546-54-6]
Formula: C23H28O7
Target: Autophagy|||Cytochromes P450|||Reactive Oxygen Species
T6S1917